Using genetic ablation of C5aR1 and transgenic overexpression of the ligand C5a in wild type and Arctic AD model mice, we provide a characterization of cellular, molecular, and transcriptomic changes that occur throughout disease progression and that are modulated by C5aR1 activation in the Arctic mouse model of AD. The gene discussed is C5AR1; the disease is Alzheimer disease.